4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-035017
EVP, Preclinical Development gave up 10,920 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Holsinger Leslie EVP, Preclinical Development | 2022-06-06 | Shares withheld for taxes | −10,920 | $2.86 | $31,231 | 148,080 | D |
Loading xslF345X03/doc4.xml…